Kim At Verheijden1, Saskia Braber2, Thea Leusink-Muis3, Suzan Thijssen3, Louis Boon4, Aletta D Kraneveld3, Johan Garssen5, Gert Folkerts3, Linette Em Willemsen3. 1. Faculty of Science, Utrecht Institute for Pharmaceutical Sciences, Division of Pharmacology, and k.a.t.verheijden@uu.nl. 2. Faculty of Veterinary Sciences, Division of Veterinary Pharmacy, Pharmacology, and Toxicology, Utrecht University, Utrecht, Netherlands; 3. Faculty of Science, Utrecht Institute for Pharmaceutical Sciences, Division of Pharmacology, and. 4. EPIRUS Biopharmaceuticals Netherlands BV, Utrecht, Netherlands. 5. Faculty of Science, Utrecht Institute for Pharmaceutical Sciences, Division of Pharmacology, and Nutricia Research, Immunology, Utrecht, Netherlands; and.
Abstract
BACKGROUND: In a murine model for house dust mite (HDM)-induced asthma, dietary galacto-oligosaccharides have been shown to suppress allergic symptoms. Previously, CD25+ regulatory T cells (Tregs) induced by nondigestible oligosaccharides were found to protect against allergy development. OBJECTIVE: The aim of the current study was to examine the effect of anti-CD25-induced Treg depletion in a murine HDM-induced asthma model and to study the contribution of Tregs in the protective effect of dietary intervention with galacto-oligosaccharides. METHODS: Male BALB/c mice (aged 6-8 wk) were intranasally sensitized and challenged with phosphate-buffered saline (PBS) or HDM. Two weeks before sensitization and throughout the whole experiment, mice were fed a control or 1% w/w galacto-oligosaccharide diet. Tregs were depleted by anti-mouse CD25 antibody (intraperitoneally injected). On day 14, T helper cell subtypes in lung and spleen were analyzed and cytokines were measured. Leukocyte subtypes were analyzed in the bronchoalveolar lavage fluid, and interleukin (IL)-33 and chemokines were measured in lung homogenate supernatants. RESULTS: Anti-CD25 treatment depleted CD25+ Forkhead box P3+ Tregs in the lung and spleen of control and HDM-allergic mice (P < 0.0001) by >70% while increasing the percentage of activated T helper cells (P < 0.05) and type 2 T helper cells (P < 0.05). This was associated with increased IL-10, IL-4, and IL-13 concentrations in supernatants of ex vivo restimulated lung cells (P < 0.01). Bronchoalveolar lavage fluid leukocyte numbers and percentages of eosinophils and lymphocytes were greater in HDM-allergic mice compared with PBS mice (P < 0.01) but remained unaffected by the anti-CD25 treatment. Galacto-oligosaccharides decreased airway eosinophilia compared with HDM-allergic mice fed the control diet (from 47.8% ± 6.7% to 26.6% ± 8.5%, P < 0.01). This protective effect was lost in anti-CD25-treated mice (P < 0.05). In lung homogenates of HDM-allergic mice, IL-33 was increased compared with PBS mice (from 2.8 ± 0.3 to 5.4 ± 0.6 ng protein/mg, P < 0.01). Galacto-oligosaccharides abrogated the increase in IL-33 compared with HDM-allergic mice fed the control diet (3.0 ± 0.6 ng protein/mg, P < 0.05), which was abolished by the anti-CD25 treatment (P < 0.01). CONCLUSIONS: Treg depletion enhances pulmonary type 2 T helper cell frequency and cytokine release in HDM-induced asthma in mice. Galacto-oligosaccharides decreased airway eosinophilia and IL-33 concentrations in the lung, which was abrogated by Treg depletion. This indicates that galacto-oligosaccharides have a beneficial effect in the prevention of HDM-induced allergic asthma by supporting pulmonary Treg function.
BACKGROUND: In a murine model for house dust mite (HDM)-induced asthma, dietary galacto-oligosaccharides have been shown to suppress allergic symptoms. Previously, CD25+ regulatory T cells (Tregs) induced by nondigestible oligosaccharides were found to protect against allergy development. OBJECTIVE: The aim of the current study was to examine the effect of anti-CD25-induced Treg depletion in a murine HDM-induced asthma model and to study the contribution of Tregs in the protective effect of dietary intervention with galacto-oligosaccharides. METHODS: Male BALB/c mice (aged 6-8 wk) were intranasally sensitized and challenged with phosphate-buffered saline (PBS) or HDM. Two weeks before sensitization and throughout the whole experiment, mice were fed a control or 1% w/w galacto-oligosaccharide diet. Tregs were depleted by anti-mouseCD25 antibody (intraperitoneally injected). On day 14, T helper cell subtypes in lung and spleen were analyzed and cytokines were measured. Leukocyte subtypes were analyzed in the bronchoalveolar lavage fluid, and interleukin (IL)-33 and chemokines were measured in lung homogenate supernatants. RESULTS: Anti-CD25 treatment depleted CD25+ Forkhead box P3+ Tregs in the lung and spleen of control and HDM-allergicmice (P < 0.0001) by >70% while increasing the percentage of activated T helper cells (P < 0.05) and type 2 T helper cells (P < 0.05). This was associated with increased IL-10, IL-4, and IL-13 concentrations in supernatants of ex vivo restimulated lung cells (P < 0.01). Bronchoalveolar lavage fluid leukocyte numbers and percentages of eosinophils and lymphocytes were greater in HDM-allergicmice compared with PBSmice (P < 0.01) but remained unaffected by the anti-CD25 treatment. Galacto-oligosaccharides decreased airway eosinophilia compared with HDM-allergicmice fed the control diet (from 47.8% ± 6.7% to 26.6% ± 8.5%, P < 0.01). This protective effect was lost in anti-CD25-treated mice (P < 0.05). In lung homogenates of HDM-allergicmice, IL-33 was increased compared with PBSmice (from 2.8 ± 0.3 to 5.4 ± 0.6 ng protein/mg, P < 0.01). Galacto-oligosaccharides abrogated the increase in IL-33 compared with HDM-allergicmice fed the control diet (3.0 ± 0.6 ng protein/mg, P < 0.05), which was abolished by the anti-CD25 treatment (P < 0.01). CONCLUSIONS: Treg depletion enhances pulmonary type 2 T helper cell frequency and cytokine release in HDM-induced asthma in mice. Galacto-oligosaccharides decreased airway eosinophilia and IL-33 concentrations in the lung, which was abrogated by Treg depletion. This indicates that galacto-oligosaccharides have a beneficial effect in the prevention of HDM-induced allergic asthma by supporting pulmonary Treg function.
Authors: Sylvia Brugman; Wakako Ikeda-Ohtsubo; Saskia Braber; Gert Folkerts; Corné M J Pieterse; Peter A H M Bakker Journal: Front Nutr Date: 2018-09-05
Authors: Kim A T Verheijden; Saskia Braber; Thea Leusink-Muis; Prescilla V Jeurink; Suzan Thijssen; Aletta D Kraneveld; Johan Garssen; Gert Folkerts; Linette E M Willemsen Journal: Front Immunol Date: 2018-10-23 Impact factor: 7.561
Authors: Marit Zuurveld; Nikita P van Witzenburg; Johan Garssen; Gert Folkerts; Bernd Stahl; Belinda Van't Land; Linette E M Willemsen Journal: Front Immunol Date: 2020-05-07 Impact factor: 7.561
Authors: Mahmoud I Abdel-Aziz; Susanne J H Vijverberg; Anne H Neerincx; Aletta D Kraneveld; Anke H Maitland-van der Zee Journal: Clin Exp Allergy Date: 2019-06-27 Impact factor: 5.018
Authors: Roos E M Verstegen; Atanaska I Kostadinova; Zenebech Merenciana; Johan Garssen; Gert Folkerts; Rudi W Hendriks; Linette E M Willemsen Journal: Nutrients Date: 2021-11-19 Impact factor: 5.717